Low-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma

scientific article published on 24 June 2014

Low-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/IJU.12532
P698PubMed publication ID24962105

P50authorAkihiro ItoQ77666693
Ko SatoQ86189232
P2093author name stringHideo Saito
Yoichi Arai
Koji Mitsuzuka
Yasuhiro Kaiho
Shinichi Yamashita
Haruo Nakagawa
Shunichi Namiki
Shigeyuki Yamada
P433issue11
P304page(s)1114-1119
P577publication date2014-06-24
P1433published inInternational Journal of UrologyQ15767019
P1476titleLow-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma
P478volume21

Reverse relations

cites work (P2860)
Q55664284Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma.
Q50132559Lenalidomide decreased the PSA level for castration-resistant prostate cancer: a case report
Q52882813Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled
Q64231996Relationship Between Renal Dysfunction and Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Pharyngeal Cancer: A Retrospective Cohort Study
Q60049823The continuing role of chemotherapy in the management of advanced urothelial cancer

Search more.